Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
Clinical trial NCT05985278 · UNKNOWN
Trial details
- NCT number
- NCT05985278
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2026-06-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.